Literature DB >> 6208163

Diabetic neovascularization: permeability and ultrastructure.

H Miller, B Miller, S Zonis, I Nir.   

Abstract

The permeability of newly formed blood vessels in proliferative diabetic retinopathy at different stages of development was correlated with their ultrastructural features. The young proliferating vessels were much more permeable to fluorescein than were the older vessels. Transmission electron microscopy revealed that the blood vessels within the young intravitreal proliferating fronds had intermediate interendothelial junctions, whereas the blood vessels within the old neovascular preretinal membranes had tight interendothelial junctions of the macula occludens type. Fenestrations were observed only rarely in the endothelial wall of either the young or the older proliferating vessels. We conclude that the principal route of fluorescein leakage from the newly formed blood vessels in proliferative diabetic retinopathy is via the interendothelial clefts.

Entities:  

Mesh:

Year:  1984        PMID: 6208163

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

1.  Wide-field optical coherence tomography angiography for the detection of proliferative diabetic retinopathy.

Authors:  Francesco Pichi; Scott D Smith; Emad B Abboud; Piergiorgio Neri; Elizabeth Woodstock; Steven Hay; Emily Levine; Caroline R Baumal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-05-30       Impact factor: 3.117

2.  The mouse model of oxygen-induced retinopathy: a suitable animal model for angiogenesis research.

Authors:  G A Gole; J Browning; S M Elts
Journal:  Doc Ophthalmol       Date:  1990-03       Impact factor: 2.379

3.  Fluorescein gonioangiography in diabetic neovascularisation.

Authors:  Y Ohnishi; T Ishibashi; T Sagawa
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

4.  Association of capillary density and function measures with blood pressure, fasting plasma glucose, and insulin sensitivity.

Authors:  Cynthia Cheng; Constantine Daskalakis; Bonita Falkner
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-02-01       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.